Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/12/2025

Treatment for Child's B Cirrhosis with a Single 4-cm Hepatocellular Carcinoma

Treatment Algorithm for HCC in Child's B Cirrhosis

  • Liver transplantation is the preferred option as it addresses both the tumor and the underlying cirrhosis, providing the best long-term disease-free survival 1, 2
  • Percutaneous techniques (such as radiofrequency ablation) can be considered as an alternative when transplantation is not feasible 3, 4
  • Radioactive lipiodol or chemo-embolization may be considered as options, though with less evidence supporting their efficacy 1

Why Other Options Are Less Optimal

  • Right lobectomy is too extensive for a Child's B patient and carries high morbidity and mortality risks due to compromised liver function 1, 3
  • Segmental resection may be considered in Child's A patients but is generally not recommended for Child's B patients due to higher risk of post-operative liver failure 3, 4
  • Radiofrequency ablation alone, while less invasive, does not address the underlying cirrhosis and has higher recurrence rates compared to transplantation 1

Important Considerations in Decision-Making

  • The British Journal of Cancer guidelines specifically recommend that hepatic transplantation be evaluated within a formal protocol for Child's B disease 1, 3
  • Any surgical intervention must be undertaken within a specialist setting due to the complexity of managing cirrhotic patients 1
  • For smaller lesions in Child's B patients, percutaneous techniques are recommended, but for a 4-cm lesion, transplantation offers better outcomes 3

Potential Pitfalls and Caveats

  • If transplantation is significantly delayed, bridging therapies such as radiofrequency ablation or chemo-embolization should be considered to prevent tumor progression 1, 4
  • For patients who cannot undergo transplantation, a combination of local therapies may be required to manage both the tumor and cirrhosis-related complications 3

REFERENCES

1

hepatocellular carcinoma. [LINK]

British Journal of Cancer, 2001

2

hepatocellular carcinoma. [LINK]

British Journal of Cancer, 2001

3

hepatocellular carcinoma. [LINK]

British Journal of Cancer, 2001

4

hepatocellular carcinoma. [LINK]

British Journal of Cancer, 2001